Evidence map›Paper›PMID 33748396›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)2021

Increased choroidal thickness in adults with Down syndrome.

Lajos Csincsik, Rachel Nelson, Madeleine J Walpert, Tunde Peto, Anthony Holland, Imre Lengyel

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Increased choroidal thickness in adults with Down syndrome.Alzheimer's & dementia (Amsterdam, Netherlands) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lajos CsincsikWellcome-Wolfson Institute for Experimental Medicine Queen's University Belfast Belfast UK.
Rachel NelsonWellcome-Wolfson Institute for Experimental Medicine Queen's University Belfast Belfast UK.
Madeleine J WalpertDepartment of Psychiatry University of Cambridge, Cambridge Intellectual and Developmental Disabilities Research Group Cambridge UK.
Tunde PetoWellcome-Wolfson Institute for Experimental Medicine Queen's University Belfast Belfast UK.
Anthony HollandDepartment of Psychiatry University of Cambridge, Cambridge Intellectual and Developmental Disabilities Research Group Cambridge UK.
Imre LengyelWellcome-Wolfson Institute for Experimental Medicine Queen's University Belfast Belfast UK.
Queen's University Belfast · GBUniversity of Cambridge · GB

Funding

Medical Research Council MR/N029941/1
6 · The paper itself

Abstract

introductionPeople with Down syndrome (DS) are particularly susceptible to Alzheimer's disease (AD) due to the triplication of the amyloid precursor protein (

methodsThe posterior pole of the eye for 24 adults with DS and 16 age-matched controls (Ctrl) were imaged with optical coherence tomography. Choroidal thickness (ChT) was measured and analyzed in relation to cognitive status and cerebral amyloid beta (Aβ) load.

resultsChT was increased in people with DS (pwDS) compared to Ctrl. This increase was associated with gender differences and positively correlated with cerebral Aβ load in a small subset. There was no significant correlation detected between ChT and age or cognitive status. DISCUSSION: In contrast to sAD this study found a significantly thicker choroid in pwDS. Whether these changes are related to Aβ pathology in DS needs further investigation.

Indexed as

Alzheimer's diseasebiomarkerchoroiddementiaDown syndromeenhanced depth optical coherence tomographyposterior pole imaging

Identifiers

PMID33748396
PMCPMC7967920
OpenAlexW3127309024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.